Red Cedar Capital
TEVA icon

Red Cedar Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Red Cedar Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.7M Buy
186,501
+306
+0.2% +$2.67K 1.08% 24
2022
Q3 		$1.5M Sell
186,195
-8
-0% -$71 1.04% 28
2022
Q2 		$1.4M Buy
186,203
+164
+0.1% +$1.43K 0.95% 30
2022
Q1 		$1.75M Buy
186,039
+119
+0.1% +$993 1.05% 26
2021
Q4 		$1.49M Buy
185,920
+1,250
+0.7% +$11.3K 0.85% 31
2021
Q3 		$1.8M Buy
184,670
+2,068
+1% +$19.4K 1.1% 25
2021
Q2 		$1.81M Sell
182,602
-527
-0.3% -$5.58K 1.14% 24
2021
Q1 		$2.11M Buy
183,129
+1,821
+1% +$20.9K 1.41% 21
2020
Q4 		$1.75M Buy
181,308
+67,228
+59% +$644K 1.28% 23
2020
Q3 		$1.03M Buy
114,080
+536
+0.5% +$5.67K 0.9% 31
2020
Q2 		$1.4M Sell
113,544
-1,629
-1% -$18.4K 1.27% 24
2020
Q1 		$1.03M Buy
115,173
+68,176
+145% +$698K 1.04% 28
2019
Q4 		$461K Buy
46,997
+584
+1% +$5.21K 0.35% 48
2019
Q3 		$319K Hold
46,413
– – 0.26% 50
2019
Q2 		$428K Sell
46,413
-254
-0.5% -$3.06K 0.36% 43
2019
Q1 		$732K Buy
46,667
+380
+0.8% +$6.7K 0.62% 34
2018
Q4 		$714K Buy
46,287
+40,436
+691% +$829K 0.69% 31
2018
Q3 		$126K Hold
5,851
– – 0.11% 69
2018
Q2 		$142K Hold
5,851
– – 0.13% 68
2018
Q1 		$99K Hold
5,851
– – 0.09% 73
2017
Q4 		$111K Buy
+5,851
New +$88K 0.09% 71

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Red Cedar Capital's TEVA Position: Q4 2022 in Review

Red Cedar Capital increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.16% in Q4 2022, buying an estimated $2.67K and bringing the position to 186,501 shares worth $1.7M. The position accounts for 1.08% of the portfolio, ranked #24.

Red Cedar Capital first reported a position in TEVA in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.11M in Q1 2021. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Red Cedar Capital held 186,501 shares of Teva Pharmaceutical Industries Limited worth $1.7M as of Q4 2022.
  • Red Cedar Capital bought 306 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $2.67K.
  • Teva Pharmaceutical Industries Limited made up 1.08% of Red Cedar Capital's portfolio in Q4 2022, its #24 holding.
  • Red Cedar Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and has held it in 21 quarters since.
  • Red Cedar Capital's Teva Pharmaceutical Industries Limited position peaked at $2.11M in Q1 2021.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.